Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NeuroPace (NPCE) Total Debt (2020 - 2025)

NeuroPace has reported Total Debt over the past 6 years, most recently at $58.9 million for Q4 2025.

  • Quarterly results put Total Debt at $58.9 million for Q4 2025, down 1.08% from a year ago — trailing twelve months through Dec 2025 was $58.9 million (down 1.08% YoY), and the annual figure for FY2025 was $58.9 million, down 1.08%.
  • Total Debt for Q4 2025 was $58.9 million at NeuroPace, roughly flat from $58.7 million in the prior quarter.
  • Over the last five years, Total Debt for NPCE hit a ceiling of $59.8 million in Q1 2025 and a floor of $49.4 million in Q2 2021.
  • Median Total Debt over the past 5 years was $55.4 million (2023), compared with a mean of $55.1 million.
  • Biggest five-year swings in Total Debt: dropped 5.71% in 2022 and later increased 7.76% in 2024.
  • NeuroPace's Total Debt stood at $49.8 million in 2021, then rose by 6.15% to $52.9 million in 2022, then increased by 7.64% to $57.0 million in 2023, then increased by 4.51% to $59.5 million in 2024, then decreased by 1.08% to $58.9 million in 2025.
  • The last three reported values for Total Debt were $58.9 million (Q4 2025), $58.7 million (Q3 2025), and $58.6 million (Q2 2025) per Business Quant data.